NIHR Maudsley BRC Blog

Our latest news and events

Novavax COVID-19 jab trialled at King’s CRF approved by UK drugs agency

UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.

By NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022

Love Your Liver Month

January is Love Your Liver Month! King's College Hospital and the King's CRF are at the forefront of liver research and treatment. For Love Your Liver Month, we provide a snapshot of just some of the exciting research being done at the Trust with support from the King's CRF.

By NIHR Wellcome King's Clinical Research Facility at 24 Jan 2022

Psilocybin, in 10mg or 25mg doses, has no detrimental effects in healthy people

New research from King’s College London, in partnership with COMPASS Pathways and supported by NIHR Maudsley BRC, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.

By NIHR Maudsley BRC at 4 Jan 2022

UK Disability History Month - an interview with Naomi

UK Disability History Month was the 18 November - 18 December. To mark this, Chifundo and Eleanor from the King's Clinical Research Facility interviewed Adult Nursing student Naomi, who has just finished her placement at the Facility and is just the second deaf nursing student to have trained at King's College London. 

 

By NIHR Wellcome King's Clinical Research Facility at 17 Dec 2021

Rett Syndrome Awareness Month

During Rett Syndrome Awareness Month (1 October - 31 October), we spoke to two parents who have children with Rett syndrome to find out about their experience and how research may be able to improve their lives.

By NIHR Wellcome King's Clinical Research Facility at 4 Nov 2021